This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Don't Get Excited About the Jump in Small Caps

NEW YORK (TheStreet) -- Small caps were enjoying their biggest one-day jump in more than a month on Monday, as the Russell 2000 soared more than 2% supporting new records for the S&P 500 and Dow Jones Industrial Average.

But small-cap managers and strategists were viewing the move with caution.

Greywolf Execution chief technical analyst, Mark Newton, noted that only 26% of stocks in the Russell 2000 were above their 50-day moving average compared to 59% of stocks for the S&P 500.

"We still don't have the breadth needed to support the start of a big rally," he said. In addition, only 45% of Russell 2000 stocks were above their 200-day moving average, which means the index is unlikely to touch new highs anytime soon, he added.

Chase Investment Council chief investment officer Edward Painvin and Motley Fool senior analyst Bill Mann still see small caps as expensive relative to their larger cap peers. "We're very cautious on valuations," Mann said in a phone interview.

Painvin agreed, and said despite the pullback in small caps this year -- the Russell 2000 has fallen more than 6% from its March highs -- he preferred their larger more liquid peers in the S&P 500.

Small caps have suffered this year due to their heavier weighing toward biotech and technology stocks, which were sold off after running hard in 2013 as managers shun momentum plays for value names.

Solid performance from the Russell 2000 is seen as crucial if broader markets are to push higher, with support for small companies viewed as a gauge of investor risk appetite.

Many fund managers still believe small caps will finish the year higher -- albeit behind the broader index -- given investors have few other alternatives for their cash in a rising rate environment. They advocate focusing on small companies with a history of solid earnings growth rather than "blue sky" names with high valuations.

Top gainers in the Russell 2000 on Monday included cancer-focused pharmaceutical company Tesaro (TSRO)up 18.50%, building products distributor BlueLinx  (BXC) up 18% and Accelerate Diagnostics  (AXDX)which was gaining 13.44%. Other strong performers were Sterling Construction (STRL) and Depomed (DEPO).   


-- By Jane Searle in New York

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
BXC $1.04 0.00%
TSRO $55.91 0.00%
AAPL $123.25 0.00%
FB $83.30 0.00%
GOOG $548.34 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs